Literature DB >> 10469055

Viral load and CD69 molecule expression on freshly isolated and cultured mitogen-stimulated lymphocytes of children with perinatal HIV-1 infection.

M De Martino1, M E Rossi, C Azzari, M G Gelli, F Chiarelli, L Galli, A Vierucci.   

Abstract

HIV-1 in adults changes the proportion of mitogen-stimulated lymphocytes expressing the CD69 activation molecule, but little is known about this molecule expression on lymphocytes of HIV-1-infected (HIV-1+) children. Freshly isolated CD3+, CD4+, CD8+ and CD19+ and phytohaemagglutinin (PHA)-stimulated CD3+, CD4+ and CD8+ lymphocytes co-expressing CD69 were investigated cross-sectionally (adopting a MoAb double-staining technique) in 24 HIV-1+ children with severe disease and given anti-retroviral therapy and in 24 age-matched healthy children. CD69 results in HIV-1+ children were correlated with plasma HIV-1 RNA load prospectively determined. HIV-1+ compared with healthy children had higher frequencies of freshly isolated CD3+CD69+ (2.4 +/- 2.2% versus 0.9 +/- 0.5%; P = 0.002) and CD8+CD69+ (1.5 +/- 1.1% versus 0. 5 +/- 0.2%; P < 0.0001) lymphocytes. The frequencies of CD4+CD69+ and CD19+CD69+ lymphocytes were similar. High viral load correlated with an elevated proportion of freshly isolated CD3+CD69+ and CD8+CD69+ lymphocytes. HIV-1+ children showed reduced frequencies of PHA-stimulated CD3+CD69+ (60.7 +/- 7.6% versus 86.1 +/- 7.6%; P < 0. 001), CD4+CD69+ (73.6 +/- 18.2% versus 92.6 +/- 5.1%; P < 0.001), and CD8+CD69+ (51.0 +/- 19.1% versus 65.3 +/- 15.4%; P = 0.007) lymphocytes. Virologic worsening within 6 months correlated with a low proportion of PHA-stimulated CD3+CD69+ and CD8+CD69+ lymphocytes. CD69 molecule expression reflected the coexistence of immune activation and immune deficiency in HIV-1 infection. Changes partly differed from those observed in HIV-1+ adults. CD8+CD69+ (but not CD4+CD69+) lymphocyte proportion correlated with virologic course, and an impaired ability of CD8+ lymphocytes to express CD69 upon PHA stimulation preceded a virologic worsening.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10469055      PMCID: PMC1905369          DOI: 10.1046/j.1365-2249.1999.01011.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  10 in total

1.  HIV disease in children is associated with a selective decrease in CD23+ and CD62L+ B cells.

Authors:  C Rodriguez; J K Thomas; S O'Rourke; E R Stiehm; S Plaeger
Journal:  Clin Immunol Immunopathol       Date:  1996-11

2.  Different meaning of CD38 molecule expression on CD4+ and CD8+ cells of children perinatally infected with human immunodeficiency virus type 1 infection surviving longer than five years.

Authors:  M de Martino; M E Rossi; C Azzari; M G Gelli; L Galli; A Vierucci
Journal:  Pediatr Res       Date:  1998-06       Impact factor: 3.756

3.  Induction of MHC-IIDR expression on circulating CD8+ lymphocytes in macaques infected with SIVmac239 nef-open but not with its nef-deletion mutant.

Authors:  H Akari; K Mori; I Otani; K Terao; F Ono; A Adachi; Y Yoshikawa
Journal:  AIDS Res Hum Retroviruses       Date:  1998-05-01       Impact factor: 2.205

4.  Italian guidelines for antiretroviral therapy in children with human immunodeficiency virus-type 1 infection. Italian Register for HIV Infection in Children.

Authors: 
Journal:  Acta Paediatr       Date:  1999-02       Impact factor: 2.299

5.  Interleukin-15 triggers activation and growth of the CD8 T-cell pool in extravascular tissues of patients with acquired immunodeficiency syndrome.

Authors:  C Agostini; L Trentin; R Sancetta; M Facco; C Tassinari; A Cerutti; M Bortolin; A Milani; M Siviero; R Zambello; G Semenzato
Journal:  Blood       Date:  1997-08-01       Impact factor: 22.113

6.  Circulating CD8 T lymphocytes in human immunodeficiency virus-infected individuals have impaired function and downmodulate CD3 zeta, the signaling chain of the T-cell receptor complex.

Authors:  L A Trimble; J Lieberman
Journal:  Blood       Date:  1998-01-15       Impact factor: 22.113

7.  Expression of CD69 after in vitro stimulation: a rapid method for quantitating impaired lymphocyte responses in HIV-infected individuals.

Authors:  J F Krowka; B Cuevas; D C Maron; K S Steimer; M S Ascher; H W Sheppard
Journal:  J Acquir Immune Defic Syndr Hum Retrovirol       Date:  1996-01-01

8.  Expression of the activation antigen CD69 predicts functionality of in vitro expanded peripheral blood mononuclear cells (PBMC) from healthy donors and HIV-infected patients.

Authors:  S D Nielsen; P Afzelius; A K Ersbøll; J O Nielsen; J E Hansen
Journal:  Clin Exp Immunol       Date:  1998-10       Impact factor: 4.330

9.  Prognostic significance of plasma markers of immune activation, HIV viral load and CD4 T-cell measurements.

Authors:  J L Fahey; J M Taylor; B Manna; P Nishanian; N Aziz; J V Giorgi; R Detels
Journal:  AIDS       Date:  1998-09-10       Impact factor: 4.177

10.  The human immunodeficiency virus type 1 (HIV-1) Vpu protein interferes with an early step in the biosynthesis of major histocompatibility complex (MHC) class I molecules.

Authors:  T Kerkau; I Bacik; J R Bennink; J W Yewdell; T Húnig; A Schimpl; U Schubert
Journal:  J Exp Med       Date:  1997-04-07       Impact factor: 14.307

  10 in total
  5 in total

1.  Measuring the diaspora for virus-specific CD8+ T cells.

Authors:  D R Marshall; S J Turner; G T Belz; S Wingo; S Andreansky; M Y Sangster; J M Riberdy; T Liu; M Tan; P C Doherty
Journal:  Proc Natl Acad Sci U S A       Date:  2001-05-08       Impact factor: 11.205

2.  Selective deficiency of naïve CD4+ T-lymphocytes in a child with congenital lymphoedema.

Authors:  Elena Chiappini; Luisa Galli; Maria Grazia Giudizi; Chiara Azzari; Augusto Antonio Niccoli; Sergio Romagnani; Maurizio de Martino
Journal:  Eur J Pediatr       Date:  2003-08-22       Impact factor: 3.183

3.  Highly active antiretroviral therapy restores in vitro mitogen and antigen-specific T-lymphocyte responses in HIV-1 perinatally infected children despite virological failure.

Authors:  M Peruzzi; C Azzari; L Galli; A Vierucci; M De Martino
Journal:  Clin Exp Immunol       Date:  2002-05       Impact factor: 4.330

4.  CD69 Deficiency Enhances the Host Response to Vaccinia Virus Infection through Altered NK Cell Homeostasis.

Authors:  Laura Notario; Elisenda Alari-Pahissa; Antonio de Molina; Pilar Lauzurica
Journal:  J Virol       Date:  2016-06-24       Impact factor: 5.103

5.  Aflatoxin-related immune dysfunction in health and in human immunodeficiency virus disease.

Authors:  Yi Jiang; Pauline E Jolly; Peter Preko; Jia-Sheng Wang; William O Ellis; Timothy D Phillips; Jonathan H Williams
Journal:  Clin Dev Immunol       Date:  2008
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.